Cystic fibrosis patients at risk for disease progression marked by decline in FEV1% predicted: development of the cystic fibrosis risk of disease progression score
Nathan L. Marsteller(Translational Research in Oncology), Inderpal Randhawa(Food Allergy Research and Education), Eliezer Nussbaum(Boston Children's Hospital), Tricia Morphew(University of California, Irvine)
Cited by 4
Related Papers
Adolescent pregnancy: a high risk group.
|PubMed|1997|45
Pediatric P‐ANCA vasculitis following COVID‐19
|Pediatric Pulmonology|2021|44
Successful Management of Plastic Bronchitis in a Child Post Fontan: Case Report and Literature Review
|Lung|2012|41
Resolution of Corticosteroid-Induced Diabetes in Allergic Bronchopulmonary Aspergillosis with Omalizumab Therapy: A Novel Approach
|Journal of Asthma|2009|26
Immunoglobulin Replacement Therapy: A Twenty-Year Review and Current Update
|International Archives of Allergy and Immunology|2014|26